Oppenheimer F - Search Results

1

Enteric-coated mycophenolate sodium is therapeutically equivalent to mycophenolate mofetil in de novo renal transplant patients.

Salvadori M, Holzer H, de Mattos A, Sollinger H, Arns W, Oppenheimer F, Maca J, Hall M; ERL B301 Study Groups. Salvadori M, et al. Among authors: oppenheimer f. Am J Transplant. 2004 Feb;4(2):231-6. doi: 10.1046/j.1600-6143.2003.00337.x. Am J Transplant. 2004. PMID: 14974944 Free article. Clinical Trial.

2

Estimated one-year glomerular filtration rate is the best predictor of long-term graft function following renal transplant.

Salvadori M, Rosati A, Bock A, Chapman J, Dussol B, Fritsche L, Kliem V, Lebranchu Y, Oppenheimer F, Pohanka E, Tufveson G, Bertoni E. Salvadori M, et al. Among authors: oppenheimer f. Transplantation. 2006 Jan 27;81(2):202-6. doi: 10.1097/01.tp.0000188135.04259.2e. Transplantation. 2006. PMID: 16436963

3

Follow-up after renal transplantation with organs from donors after cardiac death.

Chapman J, Bock A, Dussol B, Fritsche L, Kliem V, Lebranchu Y, Oppenheimer F, Pohanka E, Salvadori M, Tufveson G. Chapman J, et al. Among authors: oppenheimer f. Transpl Int. 2006 Sep;19(9):715-9. doi: 10.1111/j.1432-2277.2006.00337.x. Transpl Int. 2006. PMID: 16918531 Free article.

4

Impact of long-term therapy with FTY720 or mycophenolate mofetil on cardiac conduction and rhythm in stable adult renal transplant patients.

Oppenheimer F, Mulgaonkar S, Ferguson R, Grinyó J, Juarez F, Ostrowski M, Klinger M, Walker R, Torres A, Preiss R, Cremer M, Jardine A; FTY720 2216 Clinical Study Group. Oppenheimer F, et al. Transplantation. 2007 Mar 15;83(5):645-8. doi: 10.1097/01.tp.0000253421.18892.b8. Transplantation. 2007. PMID: 17353787

5

Corticosteroid-free immunosuppression with tacrolimus, mycophenolate mofetil, and daclizumab induction in renal transplantation.

Rostaing L, Cantarovich D, Mourad G, Budde K, Rigotti P, Mariat C, Margreiter R, Capdevilla L, Lang P, Vialtel P, Ortuño-Mirete J, Charpentier B, Legendre C, Sanchez-Plumed J, Oppenheimer F, Kessler M; CARMEN Study Group. Rostaing L, et al. Among authors: oppenheimer f. Transplantation. 2005 Apr 15;79(7):807-14. doi: 10.1097/01.tp.0000154915.20524.0a. Transplantation. 2005. PMID: 15818323 Clinical Trial.

6

The pharmacokinetics of mycophenolate mofetil in renal transplant recipients receiving standard-dose or low-dose cyclosporine, low-dose tacrolimus or low-dose sirolimus: the Symphony pharmacokinetic substudy.

Grinyó JM, Ekberg H, Mamelok RD, Oppenheimer F, Sánchez-Plumed J, Gentil MA, Hernandez D, Kuypers DR, Brunet M. Grinyó JM, et al. Among authors: oppenheimer f. Nephrol Dial Transplant. 2009 Jul;24(7):2269-76. doi: 10.1093/ndt/gfp162. Epub 2009 Apr 8. Nephrol Dial Transplant. 2009. PMID: 19357111

7

Predictors of success in conversion from calcineurin inhibitor to sirolimus in chronic allograft dysfunction.

Diekmann F, Budde K, Oppenheimer F, Fritsche L, Neumayer HH, Campistol JM. Diekmann F, et al. Among authors: oppenheimer f. Am J Transplant. 2004 Nov;4(11):1869-75. doi: 10.1111/j.1600-6143.2004.00590.x. Am J Transplant. 2004. PMID: 15476488 Free article. Clinical Trial.

8

Two-year outcomes in de novo renal transplant recipients receiving everolimus-facilitated calcineurin inhibitor reduction regimen from the TRANSFORM study.

Berger SP, Sommerer C, Witzke O, Tedesco H, Chadban S, Mulgaonkar S, Qazi Y, de Fijter JW, Oppenheimer F, Cruzado JM, Watarai Y, Massari P, Legendre C, Citterio F, Henry M, Srinivas TR, Vincenti F, Gutierrez MPH, Marti AM, Bernhardt P, Pascual J; TRANSFORM investigators. Berger SP, et al. Among authors: oppenheimer f. Am J Transplant. 2019 Nov;19(11):3018-3034. doi: 10.1111/ajt.15480. Epub 2019 Jul 1. Am J Transplant. 2019. PMID: 31152476 Free article. Clinical Trial.

9

Influence of age in renal transplant infections: cases and controls study.

Trouillhet I, Benito N, Cervera C, Rivas P, Cofán F, Almela M, Angeles Marcos M, Puig de la Bellacasa J, Pumarola T, Oppenheimer F, Moreno-Camacho A. Trouillhet I, et al. Among authors: oppenheimer f. Transplantation. 2005 Oct 15;80(7):989-92. doi: 10.1097/01.tp.0000173822.05877.d7. Transplantation. 2005. PMID: 16249750

10

Sequential quadruple immunosuppression including sirolimus in extended criteria and nonheartbeating donor kidney transplantation.

Diekmann F, Campistol JM, Saval N, Gutiérrez-Dalmau A, Arellano EM, Crespo M, Rossich E, Esforzado N, Cofán F, Ricart MJ, Torregrosa JV, Oppenheimer F. Diekmann F, et al. Among authors: oppenheimer f. Transplantation. 2007 Aug 15;84(3):429-32. doi: 10.1097/01.tp.0000269610.13590.52. Transplantation. 2007. PMID: 17700171 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

341 results

Search Page